• Mar 06, 2025

3 Reasons to Sell ILMN and 1 Stock to Buy Instead

What a brutal six months it’s been for Illumina. The stock has dropped 30.9% and now trades at $84.65, rattling many shareholders. This may have investors wondering how to approach the situation.

  • Mar 06, 2025

3 Reasons CHTR is Risky and 1 Stock to Buy Instead

Charter’s 17.9% return over the past six months has outpaced the S&P 500 by 12.8%, and its stock price has climbed to $383.08 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

  • Mar 06, 2025

3 Reasons to Sell EVH and 1 Stock to Buy Instead

Evolent Health has gotten torched over the last six months - since September 2024, its stock price has dropped 71.1% to $8.76 per share. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.

  • Mar 06, 2025

Kazakhstan Hikes Key Rate to 16.5% as Inflation Surges

(Bloomberg) -- Kazakhstan’s central bank unexpectedly hiked its key interest rate to help tame accelerating inflation that’s running at almost double the target. Most Read from BloombergTrump Administration Plans to Eliminate Dozens of Housing OfficesNJ College to Merge With State School After Financial StressRepublican Mayor Braces for Tariffs: ‘We Didn’t Budget for This’How Upzoning in Cambridge Broke the YIMBY MoldNYC’s Finances Are Sinking With Gauge Falling to 11-Year LowThe National Bank o